罕見皮膚病與孤兒藥
發(fā)布時間:2019-04-23 17:39
【摘要】:孤兒藥是指用于治療、預防或診斷某種罕見病的藥物或疫苗。孤兒藥因其受眾較小,藥物的注冊和研發(fā)常有相應的扶持政策。皮膚罕見病種類眾多,本文選取了皮膚科感染性皮膚病、代謝性皮膚病、自身免疫性皮膚病及遺傳性皮膚病中的數(shù)種代表性疾病,并針對疾病的發(fā)病機制、治療藥物和治療機制進行綜述,以期能提高對皮膚科罕見病及孤兒藥的認識。
[Abstract]:Orphan drugs are drugs or vaccines used to treat, prevent, or diagnose a rare disease. Orphan drugs because of their small audience, drug registration and research and development often have corresponding support policies. There are many kinds of skin infective dermatosis, metabolic dermatosis, autoimmune dermatosis and hereditary dermatosis, and aim at the pathogenesis of the disease, in this paper, we select several representative diseases in dermatology, including infectious dermatosis, metabolic dermatosis, autoimmune dermatosis and hereditary dermatosis. The therapeutic drugs and therapeutic mechanisms were reviewed in order to improve the understanding of dermatological rare diseases and orphan drugs.
【作者單位】: 中國醫(yī)學科學院北京協(xié)和醫(yī)學院 北京協(xié)和醫(yī)院皮膚科;
【基金】:國家重點研發(fā)計劃精準醫(yī)學研究重點專項“罕見病臨床隊列研究”資助項目(2016YFC0901500)
【分類號】:R751
[Abstract]:Orphan drugs are drugs or vaccines used to treat, prevent, or diagnose a rare disease. Orphan drugs because of their small audience, drug registration and research and development often have corresponding support policies. There are many kinds of skin infective dermatosis, metabolic dermatosis, autoimmune dermatosis and hereditary dermatosis, and aim at the pathogenesis of the disease, in this paper, we select several representative diseases in dermatology, including infectious dermatosis, metabolic dermatosis, autoimmune dermatosis and hereditary dermatosis. The therapeutic drugs and therapeutic mechanisms were reviewed in order to improve the understanding of dermatological rare diseases and orphan drugs.
【作者單位】: 中國醫(yī)學科學院北京協(xié)和醫(yī)學院 北京協(xié)和醫(yī)院皮膚科;
【基金】:國家重點研發(fā)計劃精準醫(yī)學研究重點專項“罕見病臨床隊列研究”資助項目(2016YFC0901500)
【分類號】:R751
【相似文獻】
相關(guān)期刊論文 前10條
1 劉玉聰;董江萍;;歐盟罕見病及孤兒藥管理現(xiàn)狀的研究[J];中國藥學雜志;2012年05期
2 何江江;張崖冰;夏蘇建;胡善聯(lián);;歐盟罕見病保障體系及啟示[J];中國衛(wèi)生政策研究;2012年07期
3 彪巍;肖永康;陳任;秦俠;馬穎;胡志;;我國罕見病患者社會支持研究[J];醫(yī)學與社會;2012年10期
4 李丹陽;詹文英;;中國罕見病非營利組織發(fā)展的特點和困境[J];大家健康(學術(shù)版);2013年18期
5 李定國;;罕見病防治:不僅僅是知識和技術(shù)[J];診斷學理論與實踐;2014年01期
6 李秀麗;;罕見病信息傳播平臺的探討與研究[J];新聞世界;2009年08期
7 吳詩瑜;張勘;;中國建立罕見病研究和防治策略的機遇與未來挑戰(zhàn)[J];上海醫(yī)藥;2011年10期
8 吳詩瑜;張勘;;關(guān)于建立罕見病研究和防治策略的思考[J];中國衛(wèi)生資源;2011年05期
9 林禹鴻;吳曉明;;歐盟應對罕見病政策措施及其對中國的啟示[J];浙江社會科學;2011年10期
10 谷景亮;魯艷芹;徐凌忠;;淺議我國的罕見病立法進展實踐[J];衛(wèi)生軟科學;2013年03期
相關(guān)會議論文 前1條
1 胡娟娟;羅安琪;許q,
本文編號:2463658
本文鏈接:http://www.sikaile.net/yixuelunwen/pifb/2463658.html
最近更新
教材專著